Skip to main content
. 2013 Apr 30;29(2):44–54. doi: 10.3393/ac.2013.29.2.44

Table 1.

Summary of study characteristics

graphic file with name ac-29-44-i001.jpg

CAIRO, CApecitabine, IRinotecan, and Oxaliplatin; FFCD, Fédération Francophone de Cancérologie Digestive.